Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avenir Wellness Solutions Inc AVRW

Healthcare
Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production... see more

Recent & Breaking News (OTCQB:AVRW)

CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery

GlobeNewswire January 4, 2018

CURE Pharmaceutical to Present at 2018 Biotech Showcase

GlobeNewswire January 3, 2018

Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders

GlobeNewswire November 7, 2017

Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis

GlobeNewswire October 3, 2017

CureDots(TM) Look to Redefine How Animal Clinical Trials Are Conducted -- CFN Media

Marketwired September 14, 2017

CURE Pharmaceutical Launches New Academic Partnership Program Providing the Company’s Proprietary CureFilm™ for More Humane and Effective Animal Research

GlobeNewswire September 6, 2017

CURE Pharmaceutical to Participate in Panel Discussion on the Future of Clinical Research using Cannabis at The Cannabis Science Conference in Portland, OR

GlobeNewswire August 29, 2017

CFN Media Exclusive Interview: CURE Pharma Discusses Vision & Breakthrough Technology

Marketwired August 28, 2017

CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis

GlobeNewswire August 22, 2017

CURE Pharma Could Take Over Where Zynerba Fell Short -- CFN Media

Marketwired August 11, 2017

Top 4 Companies Reinventing Cannabinoid Delivery -- CFN Media

Marketwired July 26, 2017

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids

GlobeNewswire July 11, 2017

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids

PR Newswire July 11, 2017

CURE Pharma Brings Innovative Drug Delivery to Cannabis & Beyond -- CFN Media

Marketwired July 7, 2017

CURE Pharmaceutical Expects Increased Demand for Its Enhanced Transdermal Drug Delivery Platform

GlobeNewswire July 5, 2017

CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board

GlobeNewswire June 27, 2017

CURE Pharma Looks to Revolutionize Cannabinoid Delivery

Marketwired June 15, 2017

Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market

GlobeNewswire June 7, 2017

CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids

GlobeNewswire May 31, 2017

CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.

GlobeNewswire May 24, 2017